CN115068389A - Multi-effect composition, essence cream and preparation method thereof - Google Patents
Multi-effect composition, essence cream and preparation method thereof Download PDFInfo
- Publication number
- CN115068389A CN115068389A CN202210873166.9A CN202210873166A CN115068389A CN 115068389 A CN115068389 A CN 115068389A CN 202210873166 A CN202210873166 A CN 202210873166A CN 115068389 A CN115068389 A CN 115068389A
- Authority
- CN
- China
- Prior art keywords
- peg
- extract
- skin
- essence cream
- essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006071 cream Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 241000218394 Magnolia liliiflora Species 0.000 claims abstract description 14
- 241001071795 Gentiana Species 0.000 claims abstract description 12
- 241000723352 Leucanthemum maximum Species 0.000 claims abstract description 7
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 6
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 6
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 23
- 229940100460 peg-100 stearate Drugs 0.000 claims description 20
- 230000001804 emulsifying effect Effects 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 11
- 108010046377 Whey Proteins Proteins 0.000 claims description 11
- 239000003995 emulsifying agent Substances 0.000 claims description 11
- 235000021119 whey protein Nutrition 0.000 claims description 11
- -1 polydimethylsiloxane Polymers 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241000723353 Chrysanthemum Species 0.000 claims description 8
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 7
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical group CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 7
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 7
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 229920006037 cross link polymer Polymers 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 7
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- 229940057910 shea butter Drugs 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 241000405414 Rehmannia Species 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 5
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 5
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical group CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 5
- 229940104261 taurate Drugs 0.000 claims description 5
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 5
- 241001673954 Magnolia sieboldii Species 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- 238000004382 potting Methods 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 239000004902 Softening Agent Substances 0.000 claims description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 230000037303 wrinkles Effects 0.000 abstract description 9
- 238000005282 brightening Methods 0.000 abstract description 8
- 230000037394 skin elasticity Effects 0.000 abstract description 6
- 230000000638 stimulation Effects 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 63
- 239000000686 essence Substances 0.000 description 62
- 210000003491 skin Anatomy 0.000 description 50
- 238000012360 testing method Methods 0.000 description 16
- 230000003020 moisturizing effect Effects 0.000 description 10
- 241000132023 Bellis perennis Species 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 3
- 206010050637 Skin tightness Diseases 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000012875 nonionic emulsifier Substances 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 240000003293 Magnolia grandiflora Species 0.000 description 2
- 235000008512 Magnolia grandiflora Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000012874 anionic emulsifier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000008233 hard water Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000037393 skin firmness Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241001135871 Gentiana scabra Species 0.000 description 1
- DUAGQYUORDTXOR-GPQRQXLASA-N Gentiopicrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1 DUAGQYUORDTXOR-GPQRQXLASA-N 0.000 description 1
- DUAGQYUORDTXOR-WULZUDSJSA-N Gentiopicrin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1 DUAGQYUORDTXOR-WULZUDSJSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000007920 Neurogenic Inflammation Diseases 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Abstract
The invention discloses a multi-effect composition, essence cream and a preparation method thereof, and relates to the technical field of cosmetics, wherein the multi-effect composition comprises the following components in parts by weight: 0.1-0.6 part of lactalbumin, 0.2-2.5 parts of Daisy chrysanthemum extract, 0.3-1.2 parts of magnolia liliflora bark extract and 0.2-5.0 parts of gentian root extract. The multi-effect composition disclosed by the invention is free of stimulation and high in safety, and has multiple effects of resisting wrinkles, tightening, moistening, brightening skin and the like. The invention also discloses an essence cream containing the multi-effect composition, and the essence cream has good stability and skin feel, and can effectively improve skin elasticity, deeply moisturize and brighten skin.
Description
Technical Field
The invention relates to the technical field of cosmetics, and particularly relates to a multi-effect composition, essence cream and a preparation method thereof.
Background
The skin care product has the advantages of whitening and tendering skin, improving the external image of people and enhancing the self-confidence of people. Dry, dull and rough skin is not desired by everyone, but with the age and the stimulation of the living environment including ultraviolet rays and dust, various problems inevitably exist. Aiming at the problems of dry, rough, loose, dull skin and the like, people adopt corresponding skin care products to carry out maintenance and care, thereby improving the condition of gradually worsening skin and enabling the skin to recover young.
The essence care products, including essence cream, essence liquid, essence lotion and the like, have high-efficiency and long-lasting skin care effects. However, most of the existing essence care products have strong single function and lack multiple effects, only have strong effects of single moisturizing, whitening and the like, and cannot solve various problems of the skin at the same time. In addition, most of the existing essences are mainly dependent on the addition of various skin conditioning agents in providing skin feel, so that the skin feel conditioner is expensive, is easy to cause dependence, and is easy to form a new stimulus to cause other damages to the skin.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a multi-effect composition, essence cream and a preparation method thereof, wherein the multi-effect composition has the advantages of no stimulation, high safety, good stability and skin feeling, wrinkle resistance, firmness, moistening and skin brightening.
In order to achieve the purpose, the invention adopts the technical scheme that: a multi-effect composition comprises the following components in parts by weight: 0.1-0.6 part of lactalbumin, 0.2-2.5 parts of Daisy chrysanthemum extract, 0.3-1.2 parts of magnolia sieboldii bark extract and 0.2-5.0 parts of gentian root extract.
In the technical scheme of the invention, the lactalbumin is an active natural signal molecule extracted from milk and can help the regeneration and recovery of mature skin; it can induce the synthesis of extracellular matrix molecules (such as type I collagen) in the dermis, making the skin more firm and increasing elasticity.
Extract of daisy (BELLIS PERENNIS): a skin whitening agent extracted from organic Daisy flower has effects of reducing melanin activity, making pigmentation more uniform, and lightening mottle. Meanwhile, the daisy extract contains a plurality of components such as tannin, saponin, mucus and the like, and has the functions of anti-inflammation, sedation and relaxation.
Magnolia GRANDIFLORA (Magnolia GRANDIFLORA) bark extract: can be used for treating sensitive skin, relieving neurogenic inflammation, and relieving skin redness.
The extract of radix Gentianae (GENTIANA SCABRA) mainly contains gentiopicroside, gentiobiose and gentisic acid, and has effects of resisting oxidation, and relieving and tranquilizing.
Through the matching combination of the natural ingredients, the obtained multi-effect composition has no stimulation and high safety, and has the effects of obviously cooperating with wrinkle resistance, tightening, moistening and skin brightening.
Preferably, the multi-effect composition comprises the following components in parts by weight: 0.2-0.4 part of lactalbumin, 0.6-1.5 parts of Daisy chrysanthemum extract, 0.3-0.8 part of magnolia sieboldii bark extract and 1.0-3.8 parts of gentian root extract.
The invention also aims to provide essence cream which contains the multi-effect composition and also comprises the following components: emulsifier, humectant, emollient, thickener, antioxidant, preservative, emulsion stabilizer, pH regulator, chelating agent and water; wherein, the emulsifier comprises potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate.
In the existing common cosmetic components, the emulsifier mainly plays roles in emulsification, dispersion, solubilization, lubrication and the like, and mainly comprises an anionic emulsifier and a nonionic emulsifier. Among them, anionic emulsifiers have poor hard water resistance, are slightly irritating, and have limited compatibility with the ingredients of the formulation. The non-ionic emulsifier has wide selectivity, hard water resistance, wide pH application range, strong emulsifying power, strong formula adaptability and low irritation.
Based on multiple effects brought by the multi-effect composition, when the multi-effect composition is further prepared into an essence cream product, the inventor adopts a unique emulsifying system and utilizes the anionic emulsifier and the nonionic emulsifier to carry out compounding, so that not only can a good emulsifying effect be ensured, but also an additional technical effect is brought at the same time under a specific proportion.
In the components of the essence cream, potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate are compounded to serve as emulsifying components, the emulsifying components can act together with a multi-effect composition under a specific proportion, no additional skin regulator is needed to be added, a good moisturizing effect and skin feel are provided, and the effects of wrinkle resistance, firmness, moisturizing and skin brightening are influenced by the synergistic effect of the emulsifying components and the multi-effect composition. If the proportion of the emulsified components is not proper, the stability of the essence cream is poor, and the effects of improving the elasticity, moisturizing and skin glossiness and using the essence cream are obviously reduced.
Preferably, the essence cream comprises the following components in percentage by mass: 0.8-9.3% of multi-effect composition, 1.9-7.0% of emulsifier, 1.3-6.64% of humectant, 5.0-17.0% of softening agent, 0.1-0.5% of thickening agent, 0.1-1.0% of antioxidant, 0.3-1.0% of preservative, 0.85-2.2% of emulsion stabilizer, 0.1-0.6% of pH regulator, 0.01-0.1% of chelating agent and the balance of water.
Preferably, the mass ratio of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate is (0.2-1.0): (1.2-4.0): (0.5-2.0).
Preferably, the mass ratio of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate is (0.4-0.6): (3.0-3.5): (0.5-1.0).
Preferably, the mass ratio of the potassium cetyl phosphate to the PEG-20 tribehenate to the PEG-100 stearate is 0.6:3.0: 1.0.
Preferably, the moisturizer comprises butylene glycol, rehmannia glutinosa extract, acetylated sodium hyaluronate, ethylhexyl glycerin and 1, 2-hexanediol;
the emollient comprises isononyl isononanoate, polydimethylsiloxane and shea butter;
the thickening agent is an acryloyl dimethyl ammonium taurate/VP copolymer;
the antioxidant is tocopherol acetate;
the preservative is phenoxyethanol;
the emulsion stabilizer comprises acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer and C14-22 alcohol;
the pH regulator comprises arginine and sodium citrate;
the chelating agent is disodium EDTA.
Preferably, the essence cream comprises the following components in percentage by mass: 0.1-0.6% of whey protein, 0.2-2.5% of Daisy chrysanthemum extract, 0.3-1.2% of Magnolia liliiflora bark extract, 0.2-5.0% of gentian root extract, 0.2-1.0% of potassium cetyl phosphate, 1.2-4.0% of behenyl PEG-20 esters, 0.5-2.0% of PEG-100 stearate, 1.0-5.0% of butanediol, 0.02-0.2% of Chinese rehmannia root extract, 0.03-0.24% of sodium hyaluronate, 0.05-0.2% of ethylhexyl glycerol, 0.2-1.0% of 1, 2-hexanediol, 2.0-7.0% of isononyl isononanoate, 2.0-6.0% of polydimethylsiloxane, 1.0-4.0% of shea butter, 0.1-0.5% of ammonium acryloyl dimethyl taurate/VP copolymer, and 0.1-1.0% of tocopherol acetate; 0.3 to 1.0 percent of phenoxyethanol, 0.05 to 0.2 percent of acrylic acid (ester)/C10 to 30 percent of alkanol acrylate cross-linked polymer, 0.8 to 2.0 percent of C14 to 22 alcohol, 0.05 to 0.4 percent of arginine, 0.05 to 0.2 percent of sodium citrate and 0.01 to 0.1 percent of EDTA disodium.
Further, the invention provides a preparation method of the essence cream, and the preparation method comprises the following steps:
(1) sequentially adding EDTA disodium, acryloyl dimethyl ammonium taurate/VP copolymer, butanediol, potassium cetyl phosphate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, Chinese rehmannia root extract and sodium acetylhyaluronate into an emulsifying pot, heating to 80-85 ℃, and uniformly stirring to obtain phase A;
(2) sequentially adding PEG-20 esters of behenyl trimaran, PEG-100 stearate, isononyl isononanoate, C14-22 alcohol, polydimethylsiloxane, tocopheryl acetate and shea butter into an oil phase pot, and heating to 80-82 ℃ to obtain a phase B;
(3) sucking the phase B into an emulsifying pot, homogenizing at the speed of 2800-3200 rpm for 4-6 minutes, adding arginine, uniformly stirring, and cooling to below 45 ℃ to obtain phase C;
(4) adding pre-dispersed water, sodium citrate and whey protein into the phase C, and homogenizing at the speed of 1800-2200 rpm for 4-6 minutes to obtain a phase D;
(5) adding pre-dissolved Daisy extract, Magnolia liliflora bark extract, phenoxyethanol, ethylhexylglycerin, 1, 2-hexanediol, and radix Gentianae extract into phase D, stirring, and cooling to below 40 deg.C to obtain the essence cream.
The preparation method of the essence cream has simple operation steps, has low requirement on processing equipment, and can realize industrial mass production.
Compared with the prior art, the invention has the following beneficial effects:
(1) the multi-effect composition takes whey protein, a marguerite extract, a magnolia sieboldii bark extract and a gentian root extract as components, and when the multi-effect composition is prepared according to a specific proportion, the components can act synergistically, so that the multi-effect composition has multiple effects of resisting wrinkles, tightening, moistening and brightening skin. In addition, the added gentian root extract and magnolia liliflora bark extract are used as anti-allergy and relieving components, so that the product is free of irritation and high in safety, and is suitable for various skin people.
(2) The essence cream disclosed by the invention is further matched with a unique emulsifying system consisting of potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate on the basis of introducing a multi-effect composition, so that the stability of the product is guaranteed, a special moisturizing effect and skin feel are provided, a plurality of skin conditioning agents are not required to be additionally added for skin feel conditioning, and the obtained essence cream can effectively improve the skin elasticity, deeply moisturize and brighten the skin.
Detailed Description
To better illustrate the objects, technical solutions and advantages of the present invention, the present invention will be further described with reference to specific examples, but the scope of the present invention and the embodiments are not limited thereto.
Example 1
According to one embodiment of the essence cream, the raw material proportion of the essence cream is shown in table 1, and the preparation method of the essence cream comprises the following steps:
(1) accurately weighing each component material in the formula components, and simultaneously cleaning production equipment;
(2) sequentially adding EDTA disodium, acryloyl dimethyl ammonium taurate/VP copolymer, butanediol, potassium cetyl phosphate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, Chinese rehmannia root extract and sodium acetylhyaluronate into an emulsifying pot, heating to 80-85 ℃, and uniformly stirring to obtain phase A;
(3) sequentially adding PEG-20 esters of Tribehenyl alcohol, PEG-100 stearate, isononyl isononanoate, C14-22 alcohol, polydimethylsiloxane, tocopheryl acetate and shea butter into an oil phase pot, and heating to 80-82 ℃ to obtain a phase B;
(4) sucking phase B into emulsifying pot, homogenizing at 3000rpm for 5 min, adding arginine, stirring, and cooling to below 45 deg.C to obtain phase C;
(5) adding pre-dispersed water, sodium citrate and whey protein into phase C, and homogenizing at 2000rpm for 5 min to obtain phase D;
(6) adding pre-dissolved Daisy extract, Magnolia liliflora bark extract, phenoxyethanol, ethylhexylglycerin, 1, 2-hexanediol, and radix Gentianae extract, stirring, and cooling to below 40 deg.C to obtain the essence cream.
Examples 2 to 6
The raw material proportions of the essence cream in the examples of the invention, examples 2-6 are shown in table 1. The preparation method is the same as that of example 1.
Table 1 composition of essence creams of examples 1 to 6 in percentage by mass (%)
Comparative example 1
The comparative example is different from example 2 only in that the components of the essence cream of the comparative example do not contain potassium cetyl phosphate.
Comparative example 2
The difference between the comparative example and the example 2 is that the components of the essence cream of the comparative example do not contain the behenyl alcohol PEG-20 ester and the PEG-100 stearate.
Comparative example 3
The comparative example differs from example 2 only in that the components of the essence cream of the comparative example do not contain potassium cetyl phosphate and PEG-20 tribehenate.
Comparative example 4
The difference between the comparative example and the example 2 is only that the addition amounts of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate in the components of the essence cream of the comparative example are respectively 0.1%, 0.5% and 0.2%.
Comparative example 5
The difference between the comparative example and the example 2 is that the addition amounts of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate in the components of the essence cream of the comparative example are respectively 2.0%, 0.3% and 3.5%.
Comparative example 6
The difference between the comparative example and the example 2 is only that the addition amounts of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate in the components of the essence cream of the comparative example are 3.0%, 6.8% and 0.1% respectively.
Comparative example 7
The difference between the comparative example and the example 2 is only that the addition amounts of the potassium cetyl phosphate, the PEG-20 tribehenate and the PEG-100 stearate in the components of the essence cream of the comparative example are respectively 0.05%, 7.0% and 3.2%.
Comparative example 8
The comparative example is different from example 2 only in that the components of the essence cream of the comparative example comprise 0.05%, 0.1% and 0.1% of whey protein, 0.1% of daisy extract and 0.1% of magnolia liliflora bark extract.
Comparative example 9
The comparative example is different from example 2 only in that the components of the essence cream of the comparative example comprise 0.8%, 0.08% and 0.05% of whey protein, an extract of marguerite and an extract of magnolia liliiflora bark.
Comparative example 10
The comparative example is different from example 2 only in that the components of the essence cream of the comparative example comprise 0.03%, 4.0% and 0.02% of whey protein, an extract of marguerite and an extract of magnolia liliiflora bark.
Comparative example 11
The comparative example is different from example 2 only in that the addition amounts of the gentian root extract and the magnolia liliflora bark extract in the components of the essence cream of the comparative example are 0.6% and 0.08%, respectively.
Comparative example 12
The comparative example is different from example 2 only in that the addition amounts of the gentian root extract and the magnolia liliflora bark extract in the components of the essence cream of the comparative example are 0.01% and 6.8% respectively.
Comparative example 13
The comparative example differs from example 2 only in that potassium cetyl phosphate in the components of the essence cream of the comparative example is replaced with span 80, a conventional emulsifier.
Comparative example 14
The comparative example is different from example 2 only in that the components of the essence cream of the comparative example do not contain whey protein, and the addition amounts of the daisy extract, the magnolia liliflora bark extract and the gentian root extract are respectively 1.5%, 0.8% and 1.0%.
Comparative example 15
The comparative example differs from example 2 only in that the whey protein in the components of the comparative example cream was replaced with oat peptide.
The essence creams of comparative examples 1 to 15 were prepared in the same manner as in example 1.
Effect example 1
In order to verify the stability performance of the essence cream of the present invention under different conditions, physicochemical performance tests were performed on the essence creams prepared in examples 1 to 6 and comparative examples 1 to 15. The results of the physicochemical properties of the essence cream, including appearance, pH, heat resistance (45. + -. 2 ℃ for 2 months), cold resistance-17. + -. 2 ℃ for 2 months, and cycle (45 ℃ at room temperature, -17 ℃ for 3 cycles), are shown in Table 2.
Table 2 results of physicochemical property test of the essence creams of examples 1 to 6 and comparative examples 1 to 15
As can be seen from Table 2, the essence creams of examples 1 to 6, comparative examples 8 to 12 and comparative examples 14 to 15 all have good stability under heat resistance (45 + -2 ℃,2 months), cold resistance-17 + -2 ℃,2 months), and cycling (45 ℃, room temperature, -17 ℃, 3 cycles). The comparative examples 1 to 3 do not completely contain the whole emulsifier components of the present invention, the amounts of potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate in the comparative examples 4 to 7 are out of the range of the present invention, the potassium cetyl phosphate in the comparative example 13 is replaced with other emulsifiers, and the obtained essence cream shows a phenomenon of delamination or slight delamination.
Effect example 2
In order to verify the performance effects of the essence cream of the invention on resisting wrinkles, tightening, moistening and moisturizing and brightening skin, the skin elasticity, the skin moisture content and the skin glossiness of the products of examples 1-6 and comparative examples 1-15 are tested, and the specific steps are as follows:
test object(s): 63 female volunteers, 30-55 years old, had wrinkles on the cheeks, dry skin, poor facial skin elasticity, and no other obvious skin problems. The random division into 21 groups, each corresponding to the compositions of test examples 1-6 and comparative examples 1-15, respectively.
The test method comprises the following steps: applying the corresponding test sample to cheek 2 times a day, once in the morning and once in the evening; the sample is pushed evenly by finger abdomen during smearing process, and the skin is massaged to make the sample be absorbed sufficiently. The application is continued for 4 weeks.
1. Skin elasticity test
By using
The MPA580 tester measures the skin tightness F4 value and the skin tightness F4 value of the skin of a test object before and after using the essence creamA smaller F4 value indicates a tighter skin. The results of the skin tightness F4 values tested are shown in table 3.
Table 3 skin tightening test results of the essences of examples 1 to 6 and comparative examples 1 to 15
As can be seen from Table 3, after the essence cream of the invention is continuously used for 4 weeks, the F4 value of skin firming is reduced, and the essence cream of the invention has the effects of resisting wrinkles and firming. Comparative examples 1 to 12 and comparative examples 14 to 15, which are inferior to the present invention in skin firmness improving effects.
2. Deep moisturizing efficacy test
The skin moisture content of the test subjects before and after the application of the essence cream was measured using a skin moisture tester (CKCorneometer CM 825, germany), and the test results are shown in table 4.
Table 4 skin moisture content test results of the essences of examples 1 to 6 and comparative examples 1 to 15
As can be seen from table 4, the essence cream of the present invention has a more significant moisturizing effect than the comparative example.
3. Skin gloss test
The skin gloss was tested using a multifunctional skin tester (CK, Germany, model GL 200).
Skin gloss increase (%) - (An-a0)/a0 × 100%.
Table 5 skin gloss test results of the essences of examples 1 to 6 and comparative examples 1 to 15
As can be seen from table 5, the essence cream of the present invention significantly increased skin gloss after 4 weeks of use.
4. Evaluation of Using Effect
In order to evaluate the comprehensive use effect of the essence cream, the use effect of a corresponding test sample is graded and evaluated by a test object, and the full score is 10.
Table 6 results of evaluation of use effects of the essences of examples 1 to 6 and comparative examples 1 to 15
From the results in table 6, in examples 1 to 6, the irritation evaluations of all the test subjects were non-irritating, and in terms of the use experience, the effects of improving the firmness and elasticity of the skin, brightening and shining the skin, achieving a good moisturizing effect, and providing fine and smooth skin feel were shown. The essence cream prepared by the invention has no stimulation and high safety, and has multiple effects of resisting wrinkles, tightening, moistening and brightening skin. From the evaluation of the effects of comparative examples 1 to 15, it was found that the essence cream of the present invention was inferior in irritation, moisturizing effect, skin feel, and improvement of skin firmness, elasticity and glossiness.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (9)
1. The multi-effect composition is characterized by comprising the following components in parts by weight: 0.1-0.6 part of lactalbumin, 0.2-2.5 parts of Daisy chrysanthemum extract, 0.3-1.2 parts of magnolia liliflora bark extract and 0.2-5.0 parts of gentian root extract.
2. The composition of claim 1, comprising the following components in parts by weight: 0.2-0.4 part of lactalbumin, 0.6-1.5 parts of Daisy chrysanthemum extract, 0.3-0.8 part of magnolia sieboldii bark extract and 1.0-3.8 parts of gentian root extract.
3. The essence cream is characterized by comprising the following components: the multi-effect composition of any one of claims 1-2, an emulsifier, a humectant, an emollient, a thickener, an antioxidant, a preservative, an emulsion stabilizer, a pH adjuster, a chelating agent, and water;
wherein the emulsifier comprises potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate.
4. The essence cream of claim 3, characterized by comprising the following components in percentage by mass: 0.8-9.3% of multi-effect composition, 1.9-7.0% of emulsifier, 1.3-6.64% of humectant, 5.0-17.0% of softening agent, 0.1-0.5% of thickening agent, 0.1-1.0% of antioxidant, 0.3-1.0% of preservative, 0.85-2.2% of emulsion stabilizer, 0.1-0.6% of pH regulator, 0.01-0.1% of chelating agent and the balance of water.
5. The essence of any of claims 3 to 4 wherein the mass ratio of potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate is (0.2-1.0): (1.2-4.0): (0.5-2.0).
6. The essence of claim 5 wherein the mass ratio of potassium cetyl phosphate, PEG-20 tribehenate and PEG-100 stearate is (0.4-0.6): (3.0-3.5): (0.5-1.0).
7. The essence of any one of claims 3 to 4, wherein the moisturizer comprises butylene glycol, rehmannia root extract of China, sodium hyaluronate acetylated, ethylhexylglycerin and 1, 2-hexanediol;
the emollient comprises isononyl isononanoate, polydimethylsiloxane and shea butter;
the thickening agent is an acryloyl dimethyl ammonium taurate/VP copolymer;
the antioxidant is tocopherol acetate;
the preservative is phenoxyethanol;
the emulsion stabilizer comprises acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer and C14-22 alcohol;
the pH regulator comprises arginine and sodium citrate;
the chelating agent is disodium EDTA.
8. The essence cream according to claim 7, which comprises the following components in percentage by mass: 0.1-0.6% of whey protein, 0.2-2.5% of Daisy chrysanthemum extract, 0.3-1.2% of Magnolia liliiflora bark extract, 0.2-5.0% of gentian root extract, 0.2-1.0% of potassium cetyl phosphate, 1.2-4.0% of behenyl PEG-20 esters, 0.5-2.0% of PEG-100 stearate, 1.0-5.0% of butanediol, 0.02-0.2% of Chinese rehmannia root extract, 0.03-0.24% of sodium hyaluronate, 0.05-0.2% of ethylhexyl glycerol, 0.2-1.0% of 1, 2-hexanediol, 2.0-7.0% of isononyl isononanoate, 2.0-6.0% of polydimethylsiloxane, 1.0-4.0% of shea butter, 0.1-0.5% of ammonium acryloyl dimethyl taurate/VP copolymer, and 0.1-1.0% of tocopherol acetate; 0.3 to 1.0 percent of phenoxyethanol, 0.05 to 0.2 percent of acrylic acid (ester)/C10 to 30 percent of alkanol acrylate cross-linked polymer, 0.8 to 2.0 percent of C14 to 22 alcohol, 0.05 to 0.4 percent of arginine, 0.05 to 0.2 percent of sodium citrate and 0.01 to 0.1 percent of EDTA disodium.
9. The method for preparing the essence cream according to claim 8, comprising the steps of:
(1) sequentially adding EDTA disodium, acryloyl dimethyl ammonium taurate/VP copolymer, butanediol, potassium cetyl phosphate, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, Chinese rehmannia root extract and sodium acetylhyaluronate into an emulsifying pot, heating to 80-85 ℃, and uniformly stirring to obtain phase A;
(2) sequentially adding PEG-20 esters of behenyl trimaran, PEG-100 stearate, isononyl isononanoate, C14-22 alcohol, polydimethylsiloxane, tocopheryl acetate and shea butter into an oil phase pot, and heating to 80-82 ℃ to obtain a phase B;
(3) sucking the phase B into an emulsifying pot, homogenizing at the speed of 2800-3200 rpm for 4-6 minutes, adding arginine, uniformly stirring, and cooling to below 45 ℃ to obtain phase C;
(4) adding pre-dispersed water, sodium citrate and whey protein into the phase C, and homogenizing at the speed of 1800-2200 rpm for 4-6 minutes to obtain a phase D;
(5) adding pre-dissolved Daisy extract, Magnolia liliflora bark extract, phenoxyethanol, ethylhexylglycerin, 1, 2-hexanediol, and radix Gentianae extract into phase D, stirring, and cooling to below 40 deg.C to obtain the essence cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210873166.9A CN115068389B (en) | 2022-07-22 | Multi-effect composition, essence cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210873166.9A CN115068389B (en) | 2022-07-22 | Multi-effect composition, essence cream and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115068389A true CN115068389A (en) | 2022-09-20 |
| CN115068389B CN115068389B (en) | 2024-04-19 |
Family
ID=
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115737489A (en) * | 2022-12-26 | 2023-03-07 | 福建省梦娇兰日用化学品有限公司 | Upgraded moisturizing cream and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101795732A (en) * | 2007-04-19 | 2010-08-04 | 玫琳凯有限公司 | Magnolia extract containing compositions |
| CN103987394A (en) * | 2011-12-09 | 2014-08-13 | 玫琳凯有限公司 | Skin care formulation |
| CN107961211A (en) * | 2011-05-10 | 2018-04-27 | 玫琳凯有限公司 | Cosmetic composition |
| CN111329811A (en) * | 2020-04-20 | 2020-06-26 | 广州市帝臣日化科技有限公司 | Moisturizing and repairing essence milk and preparation method thereof |
| US20210093724A1 (en) * | 2019-09-30 | 2021-04-01 | Concept Matrix Solutions | Topical anti-acne composition |
| CN113262192A (en) * | 2020-02-17 | 2021-08-17 | 玫琳凯有限公司 | Topical cosmetic composition |
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101795732A (en) * | 2007-04-19 | 2010-08-04 | 玫琳凯有限公司 | Magnolia extract containing compositions |
| CN107961211A (en) * | 2011-05-10 | 2018-04-27 | 玫琳凯有限公司 | Cosmetic composition |
| CN103987394A (en) * | 2011-12-09 | 2014-08-13 | 玫琳凯有限公司 | Skin care formulation |
| US20210093724A1 (en) * | 2019-09-30 | 2021-04-01 | Concept Matrix Solutions | Topical anti-acne composition |
| CN113262192A (en) * | 2020-02-17 | 2021-08-17 | 玫琳凯有限公司 | Topical cosmetic composition |
| CN111329811A (en) * | 2020-04-20 | 2020-06-26 | 广州市帝臣日化科技有限公司 | Moisturizing and repairing essence milk and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115737489A (en) * | 2022-12-26 | 2023-03-07 | 福建省梦娇兰日用化学品有限公司 | Upgraded moisturizing cream and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107582478A (en) | A kind of salubrious emollient cream | |
| CN102198055B (en) | Skin whitening lotion and preparation method thereof | |
| CN109330953B (en) | Oil-control pore-shrinking essence | |
| CN109528564B (en) | Skin care composition and cosmetic preparation | |
| CN110721120A (en) | Multifunctional skin care cream and preparation method thereof | |
| CN110368334B (en) | Chinese herbal medicine skin care product with anti-wrinkle and skin brightening effects | |
| CN105902478A (en) | Moisturizing anti-aging cosmetic containing cedrela sinensis extract and preparation method of moisturizing anti-aging cosmetic | |
| CN108771643B (en) | Nourishing and moistening repair essence | |
| CN114224761A (en) | Color cosmetic composition, preparation method and application | |
| CN112353705B (en) | Cosmetic composition, preparation method thereof and cosmetic with wrinkle removing and aging delaying effects | |
| CN111434332A (en) | Nourishing and repairing emulsion and preparation method thereof | |
| CN112294739A (en) | Multi-effect whitening composition and application thereof in moisturizer | |
| CN112754963A (en) | Application method of firming anti-wrinkle skin care product | |
| CN111991251A (en) | Water replenishing rod and preparation method thereof | |
| CN109260086B (en) | Anti-wrinkle essence, preparation method and application thereof | |
| CN114632028B (en) | Lifting and tightening cream and preparation method thereof | |
| CN115414293B (en) | Anti-aging composition and application thereof | |
| CN116617145A (en) | Rapid anti-aging repair composition and application thereof | |
| CN113768809B (en) | Composition with mild exfoliating effect and preparation method and application thereof | |
| CN115068389B (en) | Multi-effect composition, essence cream and preparation method thereof | |
| CN115068389A (en) | Multi-effect composition, essence cream and preparation method thereof | |
| CN112220706B (en) | Anti-aging composition, cream and preparation method thereof | |
| JP7305161B2 (en) | skin cosmetics | |
| CN112315866A (en) | Black plant extract and application thereof | |
| CN111773151A (en) | Whitening and freckle-removing antioxidant emulsion and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |